Actinogen Short Term Debt from 2010 to 2024

Stocks Australia . 
Stock . Actinogen Medical
ACW Stock   0.02  0  4.00%   
Actinogen Medical Short Term Debt yearly trend continues to be comparatively stable with very little volatility. Short Term Debt will likely drop to about 57.6 K in 2024. From the period from 2010 to 2024, Actinogen Medical Short Term Debt quarterly data regression had r-value of (0.89) and coefficient of variation of  109.89. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
60.7 K
Current Value
57.6 K
Quarterly Volatility
2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Actinogen Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Actinogen Medical's main balance sheet or income statement drivers, such as Interest Expense of 25.5 K, Selling General Administrative of 1.3 M or Depreciation And Amortization of 244.7 K, as well as many indicators such as . Actinogen financial statements analysis is a perfect complement when working with Actinogen Medical Valuation or Volatility modules.
  
This module can also supplement various Actinogen Medical Technical models . Check out the analysis of Actinogen Medical Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY